Pharmacies - Belize | Statista Market Forecast

The Pharmacies market in Belize is expected to witness a significant increase in revenue, reaching a projected value of BZD US$25.35m by 2024.
This growth is attributed to several factors, including an estimated annual growth rate of 4.02% from 2024 to 2029.
As a result, the market volume is projected to reach BZD US$30.87m by 2029.
When compared to other countries globally, United States is anticipated to generate the highest revenue in the Pharmacies market, with an estimated value of US$387.30bn in 2024.
This demonstrates the dominant position of the United States in terms of market size and revenue generation.
In terms of per capita revenue, in Belize is expected to generate BZD US$60.83 per person in 2024.
This figure provides an insight into the contribution of the Pharmacies market to the overall economy of Belize, highlighting the importance of this sector in terms of generating revenue and serving the population's healthcare needs.
In Belize, the pharmacy market is experiencing a shift towards natural and herbal remedies, reflecting the country's emphasis on traditional healing practices.

Definition:
Pharmacies are physical or digital places where mainly pharmaceuticals and medical products are sold. Additionally, they also sell other items that are generally found in a pharmacy, such as food supplements, cosmetic products, and other health-related goods. A large proportion of pharmaceuticals are only available on prescription; the rest of the product range of pharmacies is sold over the counter (OTC). Besides selling products, pharmacies also advise customers, inform them about undesirable effects of the products, and detect possible interactions with other medicines.

Structure:
The Pharmacies market consists of two markets: Prescriptions Drugs and OTC Products. The Prescription Drugs market covers all products – mainly pharmaceuticals – that are only available on prescription. The OTC Products market comprises all products that are sold over the counter (OTC), including pharmaceuticals, medical devices, and other items that are generally found in a pharmacy.

Additional information:
The KPIs shown include revenue, revenue growth, average revenue per pharmacy, average revenue per capita, number of pharmacies, pharmacy density, users, and the online sales share for the OTC Products market. Revenues are generated through offline and online spending by (B2C) consumers and include VAT. B2B and B2G sales as well as other pharmaceutical sales through hospitals or retail stores, such as supermarkets, are not included.
For more information on the data displayed, use the info button next to the boxes.

Prescription pharmaceuticals
Prescription medical products
OTC pharmaceuticals
OTC medical products
Pharmacy-usual items

Services such as vaccinations
Sales through hospitals or retail stores

The Pharmacies market in Belize has been experiencing significant growth in recent years. Customer preferences and local special circumstances have played a key role in shaping this trend. Additionally, underlying macroeconomic factors have contributed to the development of the market. Customer preferences in Belize have shifted towards a greater emphasis on health and wellness. As people become more conscious of their overall well-being, there has been an increased demand for pharmaceutical products and services. This trend is not unique to Belize, as it is also observed worldwide. The growing awareness of the importance of maintaining good health has led to a higher demand for medications, vitamins, and other health-related products. Trends in the market indicate a rise in the number of pharmacies in Belize. As the demand for pharmaceutical products increases, entrepreneurs and investors have recognized the potential for growth in this sector. This has led to the establishment of new pharmacies across the country, providing consumers with a wider range of options and improving accessibility to healthcare products. The expansion of the market is also driven by the increasing availability of generic medications, which are often more affordable than brand-name drugs. Local special circumstances in Belize have contributed to the development of the Pharmacies market. The country's healthcare system is primarily based on public healthcare facilities, which often face challenges in meeting the healthcare needs of the population. As a result, many individuals turn to private pharmacies to access medications and healthcare services. The presence of private pharmacies helps to bridge the gap in healthcare provision and ensures that people have access to the medications they need. Underlying macroeconomic factors have also played a role in the growth of the Pharmacies market in Belize. The country has experienced steady economic growth in recent years, which has led to an increase in disposable income. As people have more money to spend, they are willing to invest in their health and purchase pharmaceutical products. Additionally, the government has implemented policies to promote the development of the healthcare sector, further stimulating growth in the Pharmacies market. In conclusion, the Pharmacies market in Belize has been developing rapidly due to customer preferences, local special circumstances, and underlying macroeconomic factors. The emphasis on health and wellness, the establishment of new pharmacies, the reliance on private healthcare facilities, and the steady economic growth of the country have all contributed to the growth of the market. As these factors continue to shape the market, it is likely that the Pharmacies sector in Belize will continue to expand in the coming years.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.